Allergic rhinitis, asthma, and atherosclerosis in the Bruneck and ARMY studies.

BACKGROUND Several diseases characterized by chronic inflammation and immune activation have been linked to enhanced risk for atherosclerosis. The potential association between allergies and atherosclerosis, however, remains to be defined. METHODS The association between common allergic diseases (allergic rhinitis and asthma) and 5-year development and progression of carotid atherosclerosis (Bruneck Study) and high intima-media thickness in carotid and femoral arteries (Atherosclerosis Risk Factors in Male Youngsters [ARMY] study) was investigated. The Bruneck Study is a prospective population-based survey of 826 men and women aged 40 to 70 years; the ARMY study is a cross-sectional evaluation of 141 men aged 17 or 18 years. RESULTS Subjects with allergic disorders were at a significantly increased risk for high intima-media thickness in the ARMY study (odds ratio, 2.5; 95% confidence interval, 1.1-5.5; P=.03) and for atherosclerosis development and progression in the Bruneck Study (odds ratio, 3.8; 95% confidence interval, 1.4-10.2; P=.007). The associations remained significant after multivariate adjustment for a broad array of established and potential vascular risk factors. When IgE levels were substituted for the clinical allergy variable, findings were confirmed in the Bruneck Study (adjusted odds ratio, 1.7; 95% confidence interval, 1.1-8.0), for a 1-SD increase in IgE level (P=.02). CONCLUSIONS This study documents enhanced atherosclerosis among subjects with common allergic diseases. Our findings fit well with the emerging concept that key components of allergies, such as leukotrienes or mast cells, are active in human atherogenesis and further extend the growing list of immune system-mediated and chronic inflammatory disorders that have been linked with enhanced risk for atherosclerosis.

[1]  U. Thorsteinsdóttir,et al.  Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. , 2005, American journal of human genetics.

[2]  Carlos Iribarren,et al.  Are patients with asthma at increased risk of coronary heart disease? , 2004, International journal of epidemiology.

[3]  A. Lusis,et al.  Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. , 2004, The New England journal of medicine.

[4]  Qingbo Xu,et al.  Autoimmune and inflammatory mechanisms in atherosclerosis. , 2004, Annual review of immunology.

[5]  J. Gulcher,et al.  The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke , 2004, Nature Genetics.

[6]  G. Stingl,et al.  Underestimation of allergies in elderly patients , 2004, The Lancet.

[7]  A. Togias Systemic effects of local allergic disease. , 2004, The Journal of allergy and clinical immunology.

[8]  I. McInnes,et al.  Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. , 2003, Circulation.

[9]  Duanping Liao,et al.  Lung function and incident coronary heart disease: the Atherosclerosis Risk in Communities Study. , 2003, American journal of epidemiology.

[10]  Ruurd van der Zee,et al.  Cardiovascular Risk Factors and Atherosclerosis in Young Males: ARMY Study (Atherosclerosis Risk-Factors in Male Youngsters) , 2003, Circulation.

[11]  J. Bousquet,et al.  Validation of the classification of ARIA (allergic rhinitis and its impact on asthma) , 2003, Allergy.

[12]  Qingbo Xu,et al.  Active and Passive Smoking, Chronic Infections, and the Risk of Carotid Atherosclerosis: Prospective Results From the Bruneck Study , 2002, Stroke.

[13]  A. Lusis,et al.  Identification of 5-Lipoxygenase as a Major Gene Contributing to Atherosclerosis Susceptibility in Mice , 2002, Circulation research.

[14]  P. Demoly,et al.  ERASM, a pharmacoepidemiologic survey on management of intermittent allergic rhinitis in every day general medical practice in France , 2002, Allergy.

[15]  Werner Poewe,et al.  Chronic Infections and the Risk of Carotid Atherosclerosis: Prospective Results From a Large Population Study , 2001, Circulation.

[16]  Bert Brunekreef,et al.  Relation between airborne pollen concentrations and daily cardiovascular and respiratory-disease mortality , 2000, The Lancet.

[17]  S. Kiechl,et al.  Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[18]  D. Postma,et al.  Eosinophilia and positive skin tests predict cardiovascular mortality in a general population sample followed for 30 years. , 1999, American journal of epidemiology.

[19]  S. Kiechl,et al.  The natural course of atherosclerosis. Part I: incidence and progression. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[20]  B. Metzler,et al.  The role of mast cells in atherosclerosis. , 1997, International archives of allergy and immunology.

[21]  R. Langer,et al.  IgE predicts future nonfatal myocardial infarction in men. , 1996, Journal of clinical epidemiology.

[22]  P. Enright,et al.  Asthma and its association with cardiovascular disease in the elderly. The Cardiovascular Health Study Research Group. , 1996, The Journal of asthma : official journal of the Association for the Care of Asthma.

[23]  S. Kiechl,et al.  Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis. A population-based study. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[24]  Qingbo Xu,et al.  Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis , 1993, The Lancet.

[25]  E. Karaagaoglu,et al.  Levels of IgE in the serum of patients with coronary arterial disease. , 1991, International journal of cardiology.

[26]  D. Cook,et al.  Short stature, lung function and risk of a heart attack. , 1989, International journal of epidemiology.

[27]  S. Coughlin,et al.  IgE and cardiovascular disease. Results from a population-based study. , 1987, The American journal of medicine.

[28]  H. Wedel,et al.  Peak expiratory flow and risk of cardiovascular disease and death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. , 1986, American journal of epidemiology.